Results 21 to 30 of about 427,403 (264)
Non-alcoholic fatty liver disease (NAFLD) is characterized by the abnormal buildup of lipids in the liver tissue. Non-alcoholic fatty liver (NAFL) may progress to non-alcoholic steatohepatitis.
Zhixian Zhu +4 more
doaj +1 more source
Non-alcoholic steatohepatitis (NASH) is an epidemic metabolic disease with limited therapeutic strategies. Cumulative data support the pivotal role of gut microbiota in NASH.
Da Zhou +6 more
doaj +1 more source
Fatty liver disease: A gutsy way to prevent disease progression A treatment for non-alcoholic fatty liver disease that incorporates a metabolite found in the gut could prevent progression to a more serious liver condition. Drugs that enhance the activity
Da Zhou +8 more
doaj +1 more source
Background:Non-alcoholic fatty liver disease (NAFLD) is a global health problem affecting more than a quarter of the entire adult population. Both monocytes and high-density lipoprotein cholesterol (HDL-C) were found to participate in the progression of ...
Liping Wang +8 more
doaj +1 more source
Metabolism of Fatty Livers [PDF]
EARLIER work on the metabolism of fatty livers by Ennor1 showed that the oxygen consumption and the acetoacetic acid production of liver slices from guinea pigs poisoned with carbon tetrachloride is considerably in excess of normal. Since adenosinetriphosphate is essential for the oxidation of fatty acids2, it was considered of interest to determine a ...
A H, ENNOR, L A, STOCKEN
openaire +2 more sources
Background & Aims: OATP1B3/SLCO1B3 is a human liver-specific transporter for the clearance of endogenous compounds (eg, bile acid [BA]) and xenobiotics.
Qiong Pan +16 more
doaj +1 more source
Fatty liver is a growing health problem worldwide. It might evolve to nonalcoholic steatohepatitis, cirrhosis and cause hepatocellular carcinoma. This disease, which has increased because of eating habits, changes in food content and lifestyle, affects people from childhood. The most important risk factors are obesity and insulin resistance.
ÖZTÜRK, YEŞİM, Soylu, Ozlem Bekem
openaire +3 more sources
Background: Cholesteryl ester storage disease (CESD) is a rare genetic condition caused due to deficiency of the enzyme lysosomal acid lipase (LAL). The condition is characterized by poor growth, dyslipidemia, and fatty liver. There is currently no data on the prevalence of this condition in the Indian population. It can easily
Jaya Agarwal +3 more
openaire +2 more sources
A 39-year-old man was referred to our clinic for liver diseases for a liver mass incidentally found on CT done to rule out kidney stones (figure 1A). In our clinic, he was asymptomatic with regular bowel habits. He denied episodes of jaundice, did not have skin tattoos, never smoked or used illicit drugs and rarely consumed alcohol.
Dirk J van der Windt +6 more
openaire +3 more sources
Background and Aims: Recent studies reported that the hepatic expression of AQP8 and AQP9 was downregulated in bile duct-ligated (BDL) rats and that overexpression of human AQP1 in the rat liver attenuated cholestasis.
Min Liao +10 more
doaj +1 more source

